Straits Times Index
3,336.59 +13.21 (+0.40%) Nikkei
38,487.90 +433.77 (+1.14%) Hang Seng
18,079.61 -150.58 (-0.83%) FTSE 100
8,275.38 +44.33 (+0.54%) Bitcoin USD
67,639.40 +539.82 (+0.80%) CMC Crypto 200
1,423.60 -4.97 (-0.35%)
NARI Oct 2024 55.000 call
| Previous close | 5.50 |
| Open | 5.50 |
| Bid | 2.20 |
| Ask | 7.00 |
| Strike | 55.00 |
| Expiry date | 2024-10-18 |
| Day's range | 5.50 - 5.50 |
| Contract range | N/A |
| Volume | |
| Open interest | 63 |
GuruFocus.comDirector William Hoffman Sells 60,000 Shares of Inari Medical Inc (NARI)
On May 28, 2024, William Hoffman, Director at Inari Medical Inc (NASDAQ:NARI), executed a sale of 60,000 shares of the company.
GlobeNewswireOculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board
Shareholders approved all agenda items and proposals of the Board of DirectorsRobert K. Warner, M.B.A. and Arshad M. Khanani, M.D., M.A., FASRS elected as members of the Board of DirectorsBaruch D. Kuppermann, M.D., Ph.D. and Frank G. Holz, M.D., Ph.D. appointed as members of the Scientific Advisory BoardOculis established a CHF 50 million flexible loan facility with funds and accounts managed by BlackRock ZUG, Switzerland, May 30, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: O
ZacksInari Medical (NARI) Sues Truvic on Patent Infringement
Inari Medical (NARI) files a patent infringement lawsuit against Imperative Care and its subsidiary Truvic over intentionally copying and overlapping the designs of Inari Medical's products.
